Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03951064 · ClinicalTrials.gov registry record · NA
Providing Optimal PEEP During Mechanical Ventilation for Obese Patients Using Esophageal Balloon
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03951064: Clinical Trial NA study, sponsored by University of North Carolina, Chapel Hill.
NCT03951064 is a NA study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03951064, a NA study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This is a research study to determine if identifying an optimal level of positive end-expiratory pressure (PEEP) targeted specifically to individualized patient characteristics will shorten the time on the ventilator. Participants will have catheter placed through the nose into the esophagus to measure the pressure inside the chest. This catheter will remain until the patient is freed from the ventilator. Participants will be randomized to usual care or to have the level of PEEP determined by the esophageal balloon pressure readings. The total time spent on the ventilator will be recorded.
Primary Outcome
The number of days a patient is alive and free from the ventilator up to day 28.
Interventions
- DEVICE Esophageal balloon
- PROCEDURE Intervention Spontaneous Breathing Trial (SBT) and Extubation
- PROCEDURE Control Spontaneous Breathing Trial and Extubation
- PROCEDURE Intervention Weaning after Tracheostomy
- PROCEDURE Control Weaning after Tracheostomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-03-31 |
| Est. Completion | 2022-12-06 |
| Phase | NA |
Why NCT03951064 stopped before completion
NCT03951064 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 5 interventions - of which Esophageal balloon is the first listed.
NCT03951064 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03951064 about?
NCT03951064 is a clinical study titled "Providing Optimal PEEP During Mechanical Ventilation for Obese Patients Using Esophageal Balloon". This is a research study to determine if identifying an optimal level of positive end-expiratory pressure (PEEP) targeted specifically to individualized patient characteristics will shorten the time on the ventilator. Participants will have catheter placed through the nose into the esophagus to mea...
What is the current status of trial NCT03951064?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2021-03-31. Estimated completion is 2022-12-06.
What interventions are being tested in trial NCT03951064?
The interventions under investigation include: Esophageal balloon (DEVICE), Intervention Spontaneous Breathing Trial (SBT) and Extubation (PROCEDURE), Control Spontaneous Breathing Trial and Extubation (PROCEDURE), Intervention Weaning after Tracheostomy (PROCEDURE), Control Weaning after Tracheostomy (PROCEDURE).
Who is sponsoring clinical trial NCT03951064?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03951064's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI